| __timestamp | Rhythm Pharmaceuticals, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1213000 | 7751000 |
| Thursday, January 1, 2015 | 3425000 | 10251000 |
| Friday, January 1, 2016 | 6311000 | 9575000 |
| Sunday, January 1, 2017 | 9518000 | 10912000 |
| Monday, January 1, 2018 | 28080000 | 11049000 |
| Tuesday, January 1, 2019 | 36550000 | 11646000 |
| Wednesday, January 1, 2020 | 46125000 | 13265000 |
| Friday, January 1, 2021 | 68486000 | 25805000 |
| Saturday, January 1, 2022 | 92032000 | 35182000 |
| Sunday, January 1, 2023 | 117532000 | 94999000 |
In pursuit of knowledge
In the dynamic world of biotechnology, understanding financial trends is crucial. Rhythm Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. have shown distinct patterns in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Rhythm Pharmaceuticals saw a staggering increase of over 9,500% in SG&A expenses, peaking at approximately $117 million in 2023. This reflects their aggressive expansion and investment in operational capabilities. In contrast, Viridian Therapeutics, while also increasing their SG&A spending, exhibited a more moderate growth of around 1,200%, reaching nearly $95 million in 2023. This divergence highlights different strategic approaches within the biotech sector. As these companies continue to evolve, their financial strategies will be pivotal in shaping their competitive edge and market positioning.
Gilead Sciences, Inc. vs Rhythm Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Alnylam Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Biogen Inc. and Rhythm Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Dr. Reddy's Laboratories Limited or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Madrigal Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for ADMA Biologics, Inc. and Rhythm Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Rhythm Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? ImmunityBio, Inc. or Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.